Pfizer — how they publish

10 posts · curated by ViralLoop

80 posts from @pfizer, Oct 2025 to Sep 2026: a typical post earns 17 likes. That is more than 72% of the 275 other S&P 500 companies we hold content for.

Pfizer Inc.@pfizer

At ASH2025, we’re sharing insights from Pfizer’s Global Unmet Needs in Multiple Myeloma Survey, highlighting how race and socioeconomic factors may impact access to care for U.S. patients. Learn more:

Opens with a number

Pfizer Inc.@pfizer

Why are more young adults getting cancer? Cancer has long been thought of as something that mostly affects older adults—but new data shows cancer diagnoses are rising in people under 50. To tackle this problem, it’ll take a global effort. Listen to the first episode of this

Opens with a question

Pfizer Inc.@pfizer

Our real-world evidence studies in metastatic breast cancer exemplify our commitment to generating evidence that complements randomized clinical trial findings. These insights help us better understand patients’ diverse treatment experiences.

Opens with an observation

Pfizer Inc.@pfizer

For more than a century, scientists studied cancer as a caricature of healthy tissue. Spatial transcriptomics is changing that. Now, with the ability to map tumors cell by cell, researchers are rethinking what’s possible in cancer treatment. Read more: t.co

Opens with an observation

Pfizer Inc.@pfizer

250 years of American innovation have shown what’s possible when different minds and ideas come together. As we look to what’s next, Pfizer is proud to build on that spirit of innovation, continuing to advance science and explore what’s possible for the future of medicine.

Opens with a number

Pfizer Inc.@pfizer

Insights from a global study show HCPs put disease control as a top priority while patients with relapsed/refractory multiple myeloma (RRMM) primarily focus on managing side effects and disease control. Read the analysis of treatment priorities.

Opens with an observation

Pfizer Inc.@pfizer

Every dose of medicine you take is the final step in a long journey—one that runs through qualified suppliers, rigorous testing, and continuous monitoring. Pfizer's Bina Nair and Kenya Edmondson walk through what it takes to make sure every dose performs the same way,

Opens with an observation

Pfizer Inc.@pfizer

Cancer research is advancing every day—but prevention and early detection matter, too. This #CancerPrevention & #EarlyDetection Month, we’re sharing how recommended screenings can help detect cancer earlier, when treatments may be most effective. Learn more:

Opens with an observation

Pfizer Inc.@pfizer

Pfizer is advancing obesity science. New Phase 2b data for our investigational GLP‑1 RA peptide show robust efficacy and favourable GI tolerability across weekly and monthly dosing, supporting our extensive pivotal program. Learn more: [link] #ADASciSessions #Obesity #GLP1

Opens with an observation

Pfizer Inc.@pfizer

For Pfizer scientist Shuo, cancer research isn’t just a job—it’s personal. A close friend’s diagnosis shaped how she sees her work and why it matters. Today, she shows up in the lab every day to help move cancer research forward. #CancerResearchMonth Read her story:

Opens with an observation